China Money Network
Login
Join

CBC Group-incubated Everest Medicines Completes $310M Series C Round

  • June 5, 2020 — 15:53 CST

This Data Is Locked!

This area is available only to Subscribers.

Everest Medicines, a Chinese innovative biopharmaceutical company incubated by CBC Group, announced that it has successfully completed US$310 million in Series C financing. It is... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: